Zheng-Xu Wang

652 total citations
21 papers, 509 citations indexed

About

Zheng-Xu Wang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Zheng-Xu Wang has authored 21 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Zheng-Xu Wang's work include Cancer Immunotherapy and Biomarkers (6 papers), Immune Cell Function and Interaction (6 papers) and Mesenchymal stem cell research (5 papers). Zheng-Xu Wang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Immune Cell Function and Interaction (6 papers) and Mesenchymal stem cell research (5 papers). Zheng-Xu Wang collaborates with scholars based in China, Singapore and United Kingdom. Zheng-Xu Wang's co-authors include Junxia Cao, Lawrence W. Stanton, Duo Li, Junli Li, Beilei Xu, Jinlong Liu, Paul Robson, Thomas Lufkin, Michael Roßbach and Jia You and has published in prestigious journals such as Journal of Biological Chemistry, ACS Nano and PLoS ONE.

In The Last Decade

Zheng-Xu Wang

21 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zheng-Xu Wang China 14 231 188 164 74 72 21 509
Abilasha Rao‐Bhatia Canada 6 302 1.3× 157 0.8× 95 0.6× 39 0.5× 37 0.5× 6 509
Monika Holubová Czechia 13 109 0.5× 212 1.1× 244 1.5× 49 0.7× 75 1.0× 34 502
Bahar Değirmenci Switzerland 5 284 1.2× 268 1.4× 59 0.4× 79 1.1× 41 0.6× 6 494
Un Cheol Yeo South Korea 8 204 0.9× 178 0.9× 84 0.5× 28 0.4× 20 0.3× 14 477
Yanique Rattigan United States 3 239 1.0× 360 1.9× 208 1.3× 58 0.8× 87 1.2× 6 594
Yanwen Yang China 15 430 1.9× 170 0.9× 164 1.0× 50 0.7× 30 0.4× 40 716
Alexander Dohnal Austria 15 231 1.0× 218 1.2× 382 2.3× 14 0.2× 65 0.9× 29 648
Jyothi Vijayaraghavan United States 8 188 0.8× 142 0.8× 55 0.3× 42 0.6× 42 0.6× 12 395
Malgorzata Kisielow Switzerland 7 170 0.7× 188 1.0× 177 1.1× 31 0.4× 16 0.2× 9 451
Ralph Rossi Australia 7 241 1.0× 133 0.7× 104 0.6× 28 0.4× 103 1.4× 11 567

Countries citing papers authored by Zheng-Xu Wang

Since Specialization
Citations

This map shows the geographic impact of Zheng-Xu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheng-Xu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheng-Xu Wang more than expected).

Fields of papers citing papers by Zheng-Xu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zheng-Xu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheng-Xu Wang. The network helps show where Zheng-Xu Wang may publish in the future.

Co-authorship network of co-authors of Zheng-Xu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zheng-Xu Wang. A scholar is included among the top collaborators of Zheng-Xu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zheng-Xu Wang. Zheng-Xu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Junxia, et al.. (2022). Clinical efficacy analysis of mesenchymal stem cell therapy in patients with COVID-19: A systematic review. World Journal of Clinical Cases. 10(27). 9714–9726. 4 indexed citations
2.
3.
Cao, Junxia, et al.. (2020). Assessment of the efficacy of passive cellular immunotherapy for glioma patients. Reviews in the Neurosciences. 31(4). 427–440. 1 indexed citations
4.
Cao, Junxia, et al.. (2019). The efficacy of anti-CD19 chimeric antigen receptor T cells for B-cell malignancies. Cytotherapy. 21(7). 769–781. 16 indexed citations
5.
Chen, Wei, et al.. (2016). Adipose tissue-derived stem cells ameliorates dermal fibrosis in a mouse model of scleroderma. Asian Pacific Journal of Tropical Medicine. 10(1). 52–56. 25 indexed citations
6.
Wang, Min, Junxia Cao, Beilei Xu, et al.. (2015). Evaluation of tumour vaccine immunotherapy for the treatment of advanced non-small cell lung cancer: a systematic meta-analysis. BMJ Open. 5(4). e006321–e006321. 8 indexed citations
7.
Cao, Junxia, Xiaoyan Zhang, Jinlong Liu, et al.. (2015). Validity of combination active specific immunotherapy for colorectal cancer: a meta-analysis of 2993 patients. Cytotherapy. 17(12). 1746–1762. 5 indexed citations
8.
Wang, Zheng-Xu, Junxia Cao, Duo Li, et al.. (2015). Clinical efficacy of autologous stem cell transplantation for the treatment of patients with type 2 diabetes mellitus: a meta-analysis. Cytotherapy. 17(7). 956–968. 25 indexed citations
9.
Wang, Min, Junxia Cao, Jianhong Pan, et al.. (2014). Adoptive Immunotherapy of Cytokine-Induced Killer Cell Therapy in the Treatment of Non-Small Cell Lung Cancer. PLoS ONE. 9(11). e112662–e112662. 33 indexed citations
10.
Cao, Junxia, Xiaoyan Zhang, Jinlong Liu, et al.. (2014). Clinical Efficacy of Tumor Antigen-Pulsed DC Treatment for High-Grade Glioma Patients: Evidence from a Meta-Analysis. PLoS ONE. 9(9). e107173–e107173. 37 indexed citations
11.
Wang, Zheng-Xu, Junxia Cao, Min Wang, et al.. (2014). Adoptive cellular immunotherapy for the treatment of patients with breast cancer: A meta-analysis. Cytotherapy. 16(7). 934–945. 44 indexed citations
12.
Wang, Zheng-Xu. (2014). Combination of chemotherapy and immunotherapy for colon cancer in China: A meta-analysis. World Journal of Gastroenterology. 20(4). 1095–1095. 38 indexed citations
13.
Wang, Zheng-Xu, Duo Li, Junxia Cao, et al.. (2014). Efficacy of Autologous Bone Marrow Mononuclear Cell Therapy in Patients with Peripheral Arterial Disease. Journal of Atherosclerosis and Thrombosis. 21(11). 1183–1196. 30 indexed citations
14.
Wang, Zheng-Xu, Junli Li, Junxia Cao, et al.. (2014). Cytokine-Induced Killer Cells in the Treatment of Patients with Renal Cell Carcinoma: a Pooled Meta-analysis. Immunotherapy. 6(6). 787–795. 14 indexed citations
15.
Wang, Zheng-Xu, et al.. (2013). The Conundrum of Authoritarian Resiliency Hybrid and Nondemocratic Regimes in East Asia. 9(1). 199–219. 9 indexed citations
16.
Wang, Zheng-Xu, et al.. (2008). The Transcription Factor Zfp281 Controls Embryonic Stem Cell Pluripotency by Direct Activation and Repression of Target Genes. Stem Cells. 26(11). 2791–2799. 59 indexed citations
17.
Wang, Zheng-Xu, et al.. (2007). Oct4 and Sox2 Directly Regulate Expression of Another Pluripotency Transcription Factor, Zfp206, in Embryonic Stem Cells. Journal of Biological Chemistry. 282(17). 12822–12830. 52 indexed citations
18.
Wang, Zheng-Xu, Michael Roßbach, Pin Li, et al.. (2007). Zfp206 Is a Transcription Factor That Controls Pluripotency of Embryonic Stem Cells. Stem Cells. 25(9). 2173–2182. 45 indexed citations
19.
Wang, Zheng-Xu. (2006). Hu Jintao's Power Consolidation: Groups, Institutions, and Power Balance in China's Elite Politics. Issues & Studies. 42(4). 97–136. 9 indexed citations
20.
Wang, Zheng-Xu. (2001). Expression of liver cancer associated gene HCCA3. World Journal of Gastroenterology. 7(6). 821–821. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abilasha Rao‐Bhatia Breakdown of academic impact, for papers by Monika Holubová Breakdown of academic impact, for papers by Bahar Değirmenci Breakdown of academic impact, for papers by Un Cheol Yeo Breakdown of academic impact, for papers by Yanique Rattigan Breakdown of academic impact, for papers by Yanwen Yang Breakdown of academic impact, for papers by Alexander Dohnal Breakdown of academic impact, for papers by Jyothi Vijayaraghavan Breakdown of academic impact, for papers by Malgorzata Kisielow Breakdown of academic impact, for papers by Ralph Rossi
Rankless by CCL
2026